Patient Protection and Affordable Care Act (PPACA); Oregon Emerging Infections Pr

描述(由申请人提供)：CDC的10个州新发感染计划(EIP)的目的是进行超出大多数卫生部门常规职能的监测和流行病学研究，回答国家公共卫生重要性的问题，并培训未来的流行病学家。《平价医疗法案》资金的目的是支持和扩展现有EIP站点的能力，以及启动与流感和医疗保健获得性感染(HAI)相关的新项目。PPACA资金将由俄勒冈州公共卫生司用于加强对目前在俄勒冈州的EIP网络的基本基础设施的支持。这些资金将用于支持目前从事EIP相关项目的人员，为各种利益攸关方提供培训和教育，扩大我们州和全国的信息技术和交流努力，并开展新的项目。具体来说，资金将用于4个重点领域：1)额外雇用3.0 FTE以支持多个EIP活动。2)获得有关监测和流行病学领域的教育和培训--即感染控制和健康信息。最多8名EIP人员将接受感染控制方面的额外教育和培训，最多15名EIP人员将接受卫生信息实践方面的高级教育和培训。3)支持信息技术，以便从波特兰大都市区的血液透析中心捕获有关血液感染的数据。4)聘请1.75FTE，以加强与禽流感和流感有关的一般流行病学和实验室能力。俄勒冈州的EIP将致力于建立一个评估和验证血液感染监测的标准。此外，使用聚合酶链式反应对波特兰大城市EIP集水区内住院的流感患者的分离株进行分型/分型，将提高俄勒冈州流感的流行病学和实验室能力。此外，EIP流感项目将开展一项研究，以完善俄勒冈州的流感负担预测。新的利益相关者将是血液透析中心，这些中心将被要求向ACDP提交阳性血流感染通知。这一融资机会所做的所有其他努力将用于维持和加强目前与EIP的长期利益相关者(即俄勒冈州立公共卫生实验室)的做法。拟议的新人员配置将包括1.0 FTE监督研究分析师-4；2.5 FTE研究分析师2；1.0 FTE行政专家-2；以及0.25 FTE微生物学家-2。PPACA EIP基金进一步推动了OHA的使命，即通过加强传染病监测系统，促进及早识别疫情，并提高制定优先事项、制定政策以及预防和控制传染病所需的数据质量，从而保持俄勒冈州人的健康和安全。EIP的大多数项目都不构成人类受试者研究。对于任何涉及人体研究的项目，俄勒冈州的EIP计划将向俄勒冈州公共卫生部门机构审查委员会提交方案。摘要数据(即没有患者识别码)将与疾控中心共享，并通过地方和国家公共卫生价值出版物共享。 公共卫生相关性：通过新发感染计划(EIP)为《平价医疗法案》提供资金的目的是，通过加强现有EIP网络的流行病学和实验室能力，支持州和地方卫生部门的监测基础设施。PPACA资金将由俄勒冈州公共卫生司用于加强对目前在俄勒冈州的EIP网络的基本基础设施的支持。这些资金将用于支持目前在EIP相关项目中工作的人员，为各种利益攸关方提供培训和教育，扩大我们州和全国的信息技术和交流努力，以及加强我们州内对流感和医院相关感染的监测。

DESCRIPTION (provided by applicant): The purpose of CDC's 10-state Emerging Infections Program (EIP) is to conduct surveillance and epidemiologic studies that go beyond the routine functions of most health departments, to answer questions of national public-health importance, and to train future epidemiologists. The purpose of this Affordable Care Act funding is to support and extend the capabilities of existing EIP sites, as well as to initiate new projects related to influenza and healthcare-acquired infections (HAIs). PPACA funding will be used by the Oregon Public Health Division to enhance support for the basic infrastructure of the EIP network, currently in place in Oregon. These funds will serve to support personnel currently working on EIP-related projects, offer training and education to various stakeholders, expand on the information technology and exchange efforts within our state and nationally, and to conduct the new projects. Specifically, funds will be spent on 4 focus areas: 1) Hire an additional 3.0 FTE to support multiple EIP activities. 2) Obtain education and training in relevant surveillance and epidemiologic areas - viz., infection control and health information. Up to eight EIP personnel will receive additional education and training in infection control, and up to 15 EIP personnel will receive advanced education and training in health information practices. 3) Support information technology to allow the capture of data regarding bloodstream infections from hemodialysis centers in the Portland metropolitan area. 4) Hire 1.75 FTE to enhance the general epidemiology and laboratory capacity related to HAIs and influenza. Oregon's EIP will work to establish a standard for evaluation and validation of surveillance for bloodstream infections. Additionally, the use of PCR for typing/subtyping of isolates from hospitalized patients with influenza within the Portland metropolitan EIP catchment area will both enhance the epidemiology and laboratory capacity of influenza in Oregon. Furthermore, the EIP influenza program will carry out a study to refine influenza burden projections in the state of Oregon. New stakeholders involved will be the hemodialysis centers that will be requested to submit positive blood stream infections notifications to ACDP. All other efforts undertaken by this funding opportunity will go toward sustaining and enhancing practices currently in place with longstanding EIP stakeholders (i.e. the Oregon State Public Health Laboratory) Proposed new staffing will include 1.0 FTE supervisory Research Analyst-4; 2.5 FTE Research Analyst 2; 1.0 FTE Administrative Specialist-2; and 0.25 FTE Microbiologist-2. The PPACA EIP funding furthers the OHA mission of keeping Oregonians healthy and safe through enhancement of communicable disease surveillance systems that promote early identification of outbreaks and improve the quality of data needed for priority setting, policy development, and prevention and control of infectious diseases. Most of the projects with the EIP do not constitute human subjects research. For any projects that involve research in human subjects, Oregon's EIP program will submit protocols to the Oregon Public Health Division Institutional Review Board. Summary data (i.e., without patient identifiers) will be shared with CDC and through local and national publications of public health merit. PUBLIC HEALTH RELEVANCE: The purpose of this Affordable Care Act funding through the Emerging Infections Program (EIP) is to support state and local health departments' surveillance infrastructure through enhancement of the epidemiology and laboratory capacity of the existing EIP network. PPACA funding will be used by the Oregon Public Health Division to enhance support for the basic infrastructure of the EIP network, currently in place in Oregon. These funds will serve to support personnel currently working on EIP-related projects, offer training and education to various stakeholders, expand on the information technology and exchange efforts within our state and nationally, as well as enhance surveillance for influenza & hospital-associated infections within our state.